Policy Number


IWK - 7.19 Extemporaneous Compounding of Cytotoxic Hazardous Drugs: Decision Support Guidelines


Extemporaneous compounding of cytotoxic hazardous drugs will be done by the pharmacy department using established procedures and appropriate equipment (Pharmacy Policy 7.18). This policy is intended to guide information gathering and decision making when an extemporaneously compounded product is required, but is not commercially available and there is no published recipe or other information to support its preparation.